Cancer Research UK logo.
SearchDonate
  • Search

A study comparing anetumab ravtansine (BAY 94-9343) with vinorelbine for people with mesothelioma

Overview

Cancer types:

Mesothelioma

Status:

Closed

Phase:

Phase 2

Details

This study is open to people who have advanced mesothelioma that has continued to grow despite treatment with pemetrexed and platinum based chemotherapy. Platinum based chemotherapy includes the drugs cisplatin and carboplatin.

To take part in the study you also need to have a raised level of a protein called mesothelin. To find this out the doctors test a sample of tissue (a ). The sample can be one taken in the past but if this is not available then you will need to have a biopsy.

Recruitment start: 3 December 2015

Recruitment end: 9 December 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr James Spicer

Supported by

Bayer AG

Experimental Cancer Medicine Centre (ECMC)

Last reviewed: 21 Aug 2017

CRUK internal database number: 13791

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.